Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: In the era of digital data, the Internet has become the primary source from which individuals draw healthcare information. Objective: The aim of the present study is to determine worldwide public interest in prostate cancer (PCa) treatments, their penetrance and variation, and how they compare over time. Design, setting, and participants: An analysis of worldwide search-engine trends included electronic Google queries from people who searched PCa treatment options from January 2004 to August 2018, worldwide. Join-point regression was performed. Comparisons of annual relative search volume (ARSV), average annual percentage change (AAPC), and temporal patterns were analysed to assess loss or gain of interest. Outcome measurements and statistical analysis: Evaluations were made regarding (1) interest in PCa treatments, (2) comparison of people’s interest, and (3) impact of the US Preventive Service Task Force (USPSTF) screening recommendation and National Comprehensive Cancer Network (NCCN) guideline endorsements on Internet searching for PCa treatments. Results and limitations: The mean ARSV for “prostatectomy” was 73% in 2004 and decreased thereafter, reaching a nadir of 36% in 2014 (APC: −7.2%; 95% confidence interval [CI] −7.8, −6.7; p < 0.01). Similarly, decreased interest was recorded for radiation therapy (AAPC: −3.2%; p = 0.1), high-intensity focused ultrasound (AAPC: −2.3%; p = 0.1), hormonal therapy (AAPC: −11.6%; p < 0.01), ablation therapy (AAPC: −4.1%; p < 0.01), cryotherapy (AAPC: −9.9%; p < 0.01), and brachytherapy (AAPC: −8.3%; p < 0.01). A steep interest was found in active surveillance (AS) (AAPC: +14.2%; p < 0.01) and focal therapy (AAPC: +27.5%; p < 0.01). When trends were compared before and after NCCN and USPSTF recommendations, a consistent decrease of all the treatment options was found, while interest in focal therapy and AS showed an augmented mean ARSV (+19.6 and +31.6, respectively). Conclusions: People are increasingly searching the Internet for PCa treatment options. A parallel decrease of interest was found for the nonmonitoring treatments, except for focal therapy, while an important growth of appeal has been recorded for AS. Understanding people inquisitiveness together with their degree of knowledge could be supportive to guiding counselling in the decision-making process and putting effort in certifying patient information. Patient summary: In the era of digital data, patients are increasingly searching the Internet for prostate cancer (PCa) treatment options. To safeguard patients’ knowledge, it is mandatory to understand how people seek healthcare information, guaranteeing certified and evidence-based information pertaining to PCa treatments options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting the Present with Google Trends
CHOI, H., & VARIAN, H. (2012) · Economic Record · doi:10.1111/j.1475-4932.2012.00809.x · Cited by 2,354
The use of google trends in health care research: a systematic review
Nuti, S. V., Wayda, B., Ranasinghe, I., Wang, S., Dreyer, R. P., Chen, S. I., & Murugiah, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109583 · Cited by 1,086
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp404 · Cited by 622
HERR, H. W., & O’SULLIVAN, M. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67533-7 · Cited by 250
Stevenson, F. A., Kerr, C., Murray, E., & Nazareth, I. (2007) · BMC Family Practice · doi:10.1186/1471-2296-8-47 · Cited by 212
The doctor as the second opinion and the internet as the first
Gualtieri, L. N. (2009) · CHI '09 Extended Abstracts on Human Factors in Computing Systems · doi:10.1145/1520340.1520352 · Cited by 81
Cited by
Gibson, D., Jackson, S., Shanmugasundaram, R., Seth, I., Siu, A., Ahmadi, N., Kam, J., Mehan, N., Thanigasalam, R., Jeffery, N., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55939 · Cited by 122
Davis, R., Eppler, M., Ayo-Ajibola, O., Loh-Doyle, J. C., Nabhani, J., Samplaski, M., Gill, I., & Cacciamani, G. E. (2023) · Journal of Urology · doi:10.1097/ju.0000000000003615 · Cited by 119
“Nor has any study assessed ChatGPT’s utility in urology despite research reporting frequent use of its competitor, Google, for asking urology-related questions.(9,10) Thus, we aim to understand the safety and reliability of the LLM ChatGPT for public use by (1) assessing its output quality, readability, and appropriat…”
Self-citationEppler, M., Ganjavi, C., Ramacciotti, L. S., Piazza, P., Rodler, S., Checcucci, E., Gomez Rivas, J., Kowalewski, K. F., Belenchón, I. R., Puliatti, S., et al. (2024) · European Urology · doi:10.1016/j.eururo.2023.10.014 · Cited by 117
Self-citationKeitoku, K., Nishimura, Y., Hagiya, H., Koyama, T., & Otsuka, F. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.018 · Cited by 25
Metadata
- Authors
- Cacciamani, G. E., Bassi, S., Sebben, M., Marcer, A., Russo, G. I., Cocci, A., Dell’Oglio, P., Medina, L. G., Nassiri, N., Tafuri, A., Abreu, A., Porcaro, A. B., Briganti, A., Montorsi, F., Gill, I. S., & Artibani, W.
- Venue
- European Urology Oncology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 3
- Issue
- 4
- Pages
- 481-488
- ISSN
- 2588-9311 (ISSN-L)
- OpenAlex
- W2964488478
- Cited by
- 47
- References
- 6
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. https://app.cochat.ai/papers/10.1016/j.euo.2019.07.002
- The paper
- Cacciamani, G. E., Bassi, S., Sebben, M., Marcer, A., Russo, G. I., Cocci, A., Dell’Oglio, P., Medina, L. G., Nassiri, N., Tafuri, A., Abreu, A., Porcaro, A. B., Briganti, A., Montorsi, F., Gill, I. S., & Artibani, W. (2020). Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. European Urology Oncology. https://doi.org/10.1016/j.euo.2019.07.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.